We advocate for access to & development of lifesaving medicines, tests & vaccines for people in MSF programmes & beyond. #MedicinesShouldntBeALuxury
Joined May 2009
- Tweets15.8K
- Following1.1K
- Followers23.7K
- Likes5.1K
💉First participant vaccinated in Tumaini!
Tumaini, a pivotal Phase 2/3 vaccine trial for the Bundibugyo virus causing #Ebola, will work closely with affected communities, health authorities and outbreak response partners to generate robust evidence.
“The inclusion of pregnant women and children represents an important step towards generating evidence for populations that are often excluded from clinical trials,” Valérie Briand, Head of the Research Department, Epicentre, said.
cepi.net/first-participant-v…
The ongoing Bundibugyo #Ebola virus (BDBV) outbreak has highlighted significant challenges in controlling transmission.
With currently no specific vaccine licensed against BDBV, we examined four vaccine candidates through an access lens: msfaccess.org/vaccines-2026-…
Rupa Narra is an MSF pediatrician who recently worked at an #Ebola treatment center in North Kivu, Democratic Republic of Congo, where she witnessed a harsh reality for children facing a disproportionately high risk of death.
Children cannot continue to wait.
“Treatments, vaccines, and other preventive tools should be evaluated for use in children from the outset of research efforts and made available to them without delay,” says Dr Manangama, epidemiologist and deputy director of operations at MSF.
Children are being left behind in the research of innovative medical tools for the current Ebola disease outbreak in DRC.
Children are also disproportionately impacted by the outbreak, with the youngest facing the highest risk of death.
msf.org/children-are-being-l…
MSF welcomes the adoption of the UN Political declaration on pandemic prevention, preparedness and response. It reinforces global solidarity and provides political momentum for ongoing negotiations on WHO-led Pandemic Agreement Annex on Pathogen Access and Benefit Sharing System.
ALT “We welcome progress on the pandemic agreement and urge countries engaged in further negotiations to build on this momentum and deliver a meaningful outcome with equity at its core.” Kris Torgeson, Executive Director of MSF Access.
MSF has been closely following the PABS negotiations since the start, actively sharing our position advocating for a strong, equitable and effective PABS system: msfaccess.org/pandemic-preve…
MSF Access retweeted
Our programmes in Malawi and Mali contribute to showing that it is possible to diagnose, prevent, and treat cancer in fragile and humanitarian settings.
We’re speaking at the World Cancer Conference this week to share our experience:
msf.org/delivering-cancer-ca…
MSF published a technical brief analysing access challenges concerning three Bundibugyo Ebola Virus therapeutic candidates - MBP134, remdesivir, and obeldesivir.
msfaccess.org/therapeutics-2…
Publicly available information on pricing, licensing, supply, and post-trial access remains very limited despite repeated calls for transparency.
Médecins Sans Frontières (MSF)/Doctors Without Borders is pleased to announce @KrisTorgeson as the new Executive Director of MSF Access.
msfaccess.org/kris-torgeson-…
In a commentary published in The Lancet today, MSF calls for urgent action to ensure children are included in Bundibugyo research on treatment and prevention and have timely access to paediatric formulations for oral post-exposure prophylaxis trials.
thelancet.com/journals/lanch…
What is the global double standard in #diabetes care? Authors from Voices in Action Diabetes outline the issue and explore possible solutions: newsletter.genevahealthfiles…
MSF Access retweeted
💢 Antimicrobial resistance brings added dangers to communities during conflict.
Read on to learn more 👇
msf.org/international-activi…
MSF Access retweeted
📊 Now that our tuberculosis project has concluded in Manila, Philippines, we’re reflecting on five years of work, during which we screened 51,000+ people for the disease.
msf.org/legacy-community-led…
🤔 Testing, testing: what do you know about Ebola tests?
📩 ...and, take the opportunity to subscribe to our newsletter right before the August issue!
msfaccess.org/newsletter/hav…
We are taking our demand directly to Gilead at the #AIDS2026 conference in Rio de Janeiro, Brazil - a country where people still can't access lenacapavir, even when they contributed to the clinical trials for this breakthrough HIV drug.
Read more: instagram.com/p/DbThjxUH4gy/
Luo et al (2026), in the HumAn-1 trial, conducted in Bangladesh and Tanzania, found “participants in the [insulin analogue] group spent less time in the very low range [hypoglycaemia] and had a reduced number of nocturnal hypoglycaemic events.”
thelancet.com/journals/landi…
